The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Acetylation as a major determinant to microtubule-dependent autophagy: relevance to Alzheimer’s and Parkinson disease pathology
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Accordingly, SIRT2 inhibition or its genetic deletion has provided beneficial effects in different mouse models of Huntington's disease (Chopra et al., 2012;Luthi-Carter et al., 2010), Parkinson's disease (de Oliveira et al., 2017;Esteves et al., 2019;Sun et al., 2018); and Alzheimer's disease (AD) (Bai et al., 2022;Sola-Sevilla et al., 2023;Biella et al., 2016;Wang et al., 2020).”
From Microglial SIRT2 deficiency aggravates cognitive decline and amyloid pathology in Alzheimer’s disease (2025) · cites this paper as Esteves et al., 2019
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
α-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
HDAC6 is a microtubule-associated deacetylase
Hubbert, C., Guardiola, A., Shao, R., Kawaguchi, Y., Ito, A., Nixon, A., Yoshida, M., Wang, X.-F., & Yao, T.-P. (2002) · Nature · doi:10.1038/417455a · Cited by 2,403
Acetylation of Tau Inhibits Its Degradation and Contributes to Tauopathy
Min, S.-W., Cho, S.-H., Zhou, Y., Schroeder, S., Haroutunian, V., Seeley, W. W., Huang, E. J., Shen, Y., Masliah, E., Mukherjee, C., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.08.044 · Cited by 949
Axonal transport deficits and neurodegenerative diseases
Millecamps, S., & Julien, J.-P. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3380 · Cited by 755
The acetylation of tau inhibits its function and promotes pathological tau aggregation
Cohen, T. J., Guo, J. L., Hurtado, D. E., Kwong, L. K., Mills, I. P., Trojanowski, J. Q., & Lee, V. M. Y. (2011) · Nature Communications · doi:10.1038/ncomms1255 · Cited by 724
HDAC6 and microtubules are required for autophagic degradation of aggregated huntingtin.
Iwata, A., Riley, B. E., Johnston, J. A., & Kopito, R. R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508786200 · Cited by 719
Mechanisms of tau-induced neurodegeneration
Iqbal, K., Liu, F., Gong, C.-X., Alonso, A. D. C., & Grundke-Iqbal, I. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0486-3 · Cited by 628
Green, K. N., Steffan, J. S., Martinez-Coria, H., Sun, X., Schreiber, S. S., Thompson, L. M., & LaFerla, F. M. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3203-08.2008 · Cited by 404
Microtubule-associated Protein/Microtubule Affinity-regulating Kinase (p110mark)
Meyer, H. E., Mandelkow, E.-M., Drewes, G., Trinczek, B., Illenberger, S., Biernat, J., Schmitt-Ulms, G., & Mandelkow, E. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7679 · Cited by 388
Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies
Irwin, D. J., Cohen, T. J., Grossman, M., Arnold, S. E., Xie, S. X., Lee, V. M.-Y., & Trojanowski, J. Q. (2012) · Brain · doi:10.1093/brain/aws013 · Cited by 281
Liu, F., Li, B., Tung, E., Grundke‐Iqbal, I., Iqbal, K., & Gong, C. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05955.x · Cited by 208
A role for tau at the synapse in Alzheimer’s disease pathogenesis
Pooler, A. M., Noble, W., & Hanger, D. P. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.09.018 · Cited by 203
Silva, D. F., Selfridge, J. E., Lu, J., E, L., Roy, N., Hutfles, L., Burns, J. M., Michaelis, E. K., Yan, S., Cardoso, S. M., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt247 · Cited by 133
Self-citationFrontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)
Wszolek, Z. K., Tsuboi, Y., Ghetti, B., Pickering-Brown, S., Baba, Y., & Cheshire, W. P. (2006) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-1-30 · Cited by 128
Acetylated Tau Neuropathology in Sporadic and Hereditary Tauopathies
Irwin, D. J., Cohen, T. J., Grossman, M., Arnold, S. E., McCarty-Wood, E., Van Deerlin, V. M., Lee, V. M.-Y., & Trojanowski, J. Q. (2013) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.04.025 · Cited by 125
Hoerndli, F. J., Pelech, S., Papassotiropoulos, A., & Götz, J. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05618.x · Cited by 34
Research works printed but not linked: 43
- Gao, 2008, Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression, Trends Immunol., 29, 357, 10.1016/j.it.2008.05.002 · DOI · Paper page
- Tuite, 2007, Protein misfolding and aggregation in ageing and disease: molecular processes and therapeutic perspectives, Prion, 1, 116, 10.4161/pri.1.2.4651 · DOI
- Esteves, 2011, Mitochondrial dysfunction: the road to alpha-synuclein oligomerization in PD, Park. Dis., 2011
- Silva, 2012, Mitochondrial abnormalities in Alzheimer's disease: possible targets for therapeutic intervention, Adv. Pharmacol., 64, 83, 10.1016/B978-0-12-394816-8.00003-9 · DOI · Paper page
- Morris, 1995, Axonal transport of mitochondria along microtubules and F-actin in living vertebrate neurons, J. Cell Biol., 131, 1315, 10.1083/jcb.131.5.1315 · DOI · Paper page
- Delacourte, 2005, Tauopathies: recent insights into old diseases, Folia Neuropathol., 43, 244
- Mandelkow, 2012, Biochemistry and cell biology of tau protein in neurofibrillary degeneration, Cold Spring Harb. Perspect. Med., 2, a006247, 10.1101/cshperspect.a006247 · DOI · Paper page
- Alim, 2004, Demonstration of a role for alpha-synuclein as a functional microtubule-associated protein, J. Alzheimers Dis., 6, 435, 10.3233/JAD-2004-6412 · DOI · Paper page
- Kim, 2008, Impairment of microtubule system increases alpha-synuclein aggregation and toxicity, Biochem. Biophys. Res. Commun., 365, 628, 10.1016/j.bbrc.2007.11.020 · DOI
- Schiavo, 2013, Cell biology: alternative energy for neuronal motors, Nature, 495, 178, 10.1038/495178a · DOI
- Outeiro, 2007, Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease, Science, 317, 516, 10.1126/science.1143780 · DOI · Paper page
- Esteves, 2018, Mitochondrial metabolism regulates microtubule acetylome and autophagy trough sirtuin-2: impact for Parkinson's disease, Mol. Neurobiol., 55, 1440, 10.1007/s12035-017-0420-y · DOI
- North, 2003, The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase, Mol. Cell, 11, 437, 10.1016/S1097-2765(03)00038-8 · DOI · Paper page
- Haggarty, 2003, Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation, Proc. Natl. Acad. Sci. U. S. A., 100, 4389, 10.1073/pnas.0430973100 · DOI · Paper page
- Beharry, 2014, Tau-induced neurodegeneration: mechanisms and targets, Neurosci. Bull., 30, 346, 10.1007/s12264-013-1414-z · DOI
- Silva, 2017, Mitochondrial metabolism power SIRT2-dependent deficient traffic causing Alzheimer's-disease related pathology, Mol. Neurobiol., 54, 4021, 10.1007/s12035-016-9951-x · DOI
- Cook, 2012, Loss of HDAC6, a novel CHIP substrate, alleviates abnormal tau accumulation, Hum. Mol. Genet., 21, 2936, 10.1093/hmg/dds125 · DOI
- Esteves, 2008, Mitochondrial function in Parkinson's disease cybrids containing an nt2 neuron-like nuclear background, Mitochondrion, 8, 219, 10.1016/j.mito.2008.03.004 · DOI
- Vekrellis, 2009, Inducible over-expression of wild type alpha-synuclein in human neuronal cells leads to caspase-dependent non-apoptotic death, J. Neurochem., 109, 1348, 10.1111/j.1471-4159.2009.06054.x · DOI
- Hughes, 1992, Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases, J. Neurol. Neurosurg. Psychiatry, 55, 181, 10.1136/jnnp.55.3.181 · DOI · Paper page
- Krige, 1992, Platelet mitochondrial function in Parkinson's disease, Ann. Neurol., 32, 782, 10.1002/ana.410320612 · DOI · Paper page
- Binder, 2005, Molecular characterization of mtDNA depleted and repleted NT2 cell lines, Mitochondrion, 5, 255, 10.1016/j.mito.2005.04.003 · DOI
- Cardoso, 2004, Apoptotic cell death induced by hydrogen peroxide in NT2 parental and mitochondrial DNA depleted cells, Neurochem. Int., 45, 693, 10.1016/j.neuint.2004.03.003 · DOI
- Arduino, 2012, Mitochondrial metabolism in Parkinson's disease impairs quality control autophagy by hampering microtubule-dependent traffic, Hum. Mol. Genet., 21, 4680, 10.1093/hmg/dds309 · DOI
- Janke, 2011, Post-translational regulation of the microtubule cytoskeleton: mechanisms and functions, Nat. Rev. Mol. Cell Biol., 12, 773, 10.1038/nrm3227 · DOI · Paper page
- Kochl, 2006, Microtubules facilitate autophagosome formation and fusion of autophagosomes with endosomes, Traffic, 7, 129, 10.1111/j.1600-0854.2005.00368.x · DOI · Paper page
- Esteves, 2010, Mitochondrial respiration and respiration-associated proteins in cell lines created through Parkinson's subject mitochondrial transfer, J. Neurochem., 113, 674, 10.1111/j.1471-4159.2010.06631.x · DOI
- Saha, 2004, Parkinson's disease alpha-synuclein mutations exhibit defective axonal transport in cultured neurons, J. Cell Sci., 117, 1017, 10.1242/jcs.00967 · DOI · Paper page
- Arduino, 2011, Mitochondrial fusion/fission, transport and autophagy in Parkinson's disease: when mitochondria get nasty, Park. Dis., 2011, 767230
- Santos, 2015, The impact of mitochondrial fusion and fission modulation in sporadic Parkinson's disease, Mol. Neurobiol., 52, 573, 10.1007/s12035-014-8893-4 · DOI
- Grey, 2000, Tom20-mediated mitochondrial protein import in muscle cells during differentiation, Am. J. Phys. Cell Physiol., 279, C1393, 10.1152/ajpcell.2000.279.5.C1393 · DOI
- Lee, 2001, Transgenic mouse models of tauopathies: prospects for animal models of Pick's disease, Neurology, 56, S26, 10.1212/WNL.56.suppl_4.S26 · DOI
- Esteves, 2014, The rescue of microtubule-dependent traffic recovers mitochondrial function in Parkinson's disease, Biochim. Biophys. Acta, 1842, 7, 10.1016/j.bbadis.2013.10.003 · DOI
- Cook, 2014, Acetylation: a new key to unlock tau's role in neurodegeneration, Alzheimers Res. Ther., 6, 29, 10.1186/alzrt259 · DOI
- Bulinski, 2007, Microtubule modification: acetylation speeds anterograde traffic flow, Curr. Biol., 17, R18, 10.1016/j.cub.2006.11.036 · DOI
- Xie, 2010, Acetylated microtubules are required for fusion of autophagosomes with lysosomes, BMC Cell Biol., 11, 89, 10.1186/1471-2121-11-89 · DOI · Paper page
- Cook, 2014, Acetylation of the KXGS motifs in tau is a critical determinant in modulation of tau aggregation and clearance, Hum. Mol. Genet., 23, 104, 10.1093/hmg/ddt402 · DOI · Paper page
- Iyer, 2016, The impact of N-terminal acetylation of alpha-synuclein on phospholipid membrane binding and fibril structure, J. Biol. Chem., 291, 21110, 10.1074/jbc.M116.726612 · DOI
- Esteves, 2010, Microtubule depolymerization potentiates alpha-synuclein oligomerization, Front. Aging Neurosci., 1, 5, 10.3389/neuro.24.005.2009 · DOI
- Bu, 2017, N-terminal acetylation preserves alpha-synuclein from oligomerization by blocking intermolecular hydrogen bonds, ACS Chem. Neurosci., 8, 2145, 10.1021/acschemneuro.7b00250 · DOI
- Mondragon-Rodriguez, 2014, Phosphorylation of tau protein at sites Ser(396–404) is one of the earliest events in Alzheimer's disease and Down syndrome, Neuropathol. Appl. Neurobiol., 40, 121, 10.1111/nan.12084 · DOI · Paper page
- Han, 2009, Acetylation of histone deacetylase 6 by p300 attenuates its deacetylase activity, Biochem. Biophys. Res. Commun., 383, 88, 10.1016/j.bbrc.2009.03.147 · DOI
- Gal, 2012, SIRT2 interferes with autophagy-mediated degradation of protein aggregates in neuronal cells under proteasome inhibition, Neurochem. Int., 61, 992, 10.1016/j.neuint.2012.07.010 · DOI
Cited by
The sirtuin family in health and disease
Wu, Q.-J., Zhang, T.-N., Chen, H.-H., Yu, X.-F., Lv, J.-L., Liu, Y.-Y., Liu, Y.-S., Zheng, G., Zhao, J.-Q., Wei, Y.-F., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01257-8 · Cited by 862
SIRT2: Controversy and multiple roles in disease and physiology
Wang, Y., Yang, J., Hong, T., Chen, X., & Cui, L. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100961 · Cited by 282
X-linked ubiquitin-specific peptidase 11 increases tauopathy vulnerability in women
Yan, Y., Wang, X., Chaput, D., Shin, M.-K., Koh, Y., Gan, L., Pieper, A. A., Woo, J.-A. A., & Kang, D. E. (2022) · Cell · doi:10.1016/j.cell.2022.09.002 · Cited by 144
The role of altered protein acetylation in neurodegenerative disease
Kabir, F., Atkinson, R., Cook, A. L., Phipps, A. J., & King, A. E. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1025473 · Cited by 75
“While there has been a focus on examining alterations to phosphorylation, a growing body of evidence has also implicated altered acetylation of these proteins in disease (Zhang and Benson, 2001; Cartelli et al., 2010; Esteves et al., 2019; Kim et al., 2020).”
BackgroundSola-Sevilla, N., Garmendia-Berges, M., Aleixo, M., Mera-Delgado, M., Solas, M., Tordera, R. M., García-Carracedo, L., Expósito, S., Anaya-Cubero, E., Fernández-Irigoyen, J., et al. (2025) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2025.06.016 · Cited by 5
Metadata
- Authors
- Esteves, A. R., Palma, A. M., Gomes, R., Santos, D., Silva, D. F., & Cardoso, S. M.
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Publisher
- Elsevier BV
- Published
- 2019-08
- Volume
- 1865
- Issue
- 8
- Pages
- 2008-2023
- ISSN
- 0925-4439
- Cited by
- 103
- References
- 16
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 366 d)
- Funders
- Fundação para a Ciência e a Tecnologia
- EU-FEDER (UID/NEU/04539/2013)
- European Regional Development Fund (CENTRO-01-0145-FEDER-000012-HealthyAging2020)
- Prémio Santa Casa Neurociências Mantero Belard (MB-40-2016)
- MCTES
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.